VarmX is a brand that specializes in developing innovative solutions to stop bleeding and restore blood clotting. Their lead product, VMX-C001, is designed to address bleeding in the presence of direct factor Xa anticoagulants. This groundbreaking solution aims to revolutionize the field of thrombosis and hemostasis.

With a commitment to advancing medical knowledge, VarmX actively contributes to the scientific community. They will be presenting two abstracts on their lead compound, VMX-C001, at the prestigious International Society on Thrombosis and Haemostasis (ISTH) Congress in Montreal in June 2023. This highlights their dedication to sharing their research and findings with the wider medical community.

For those interested in learning more about VarmX and their cutting-edge solutions, they can be met at the ISTH Congress in Montreal on June 24, 2023. By combining scientific expertise and a passion for improving patient outcomes, VarmX is at the forefront of developing effective treatments for bleeding disorders. Accept no compromises when it comes to your health with VarmX